ASX slips back after hitting new high ahead of Fed decision. Iron ore prices expected to drop and Harvey Norman faces class ...

Paradigm Biopharmaceuticals says the FDA has endorsed key elements of its proposed phase III knee osteoarthritis trial.

Iron ore is flirting with a move below US$90/t, as concerns around China's demand for our top export continue to play out.

Junior goldie BPM Minerals is the big winner in the resources space today, striking near the site of Capricorn's Mt Gibson ...

Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing a new Maiden Mineral Resource Estimate from Torque ...

Sun Silver (ASX:SS1) welcomes Nokomis Capital to the register and gets on rails for growth at Maverick Springs.

Rock chip sampling has delineated outcropping gold-silver-lead-zinc mineralisation outside of a resource for Argent Minerals ...

and insights straight to your inbox.

PharmAust (ASX:PAA) has submitted a request for OMPD to the European Medicines Agency (EMA) for its lead drug monepantel.

Blinklab expects rapid US approval for its phone-based autism test that can detect the condition within minutes.

Australia has a reputation as an attractive clinical trials destination generating $1.6bn for the economy in 2022, according ...